Role of Uterotonics in Reducing Intraoperative Blood Loss in Patients With PASD Undergoing Cesarean Hysterectomy
NCT ID: NCT06493968
Last Updated: 2024-07-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
70 participants
INTERVENTIONAL
2024-07-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparative Study Between Oxytocin Infusion Before and After Placental Delivery on Blood Loss During and After Cesarean Delivery .
NCT06889155
Control of Blood Loss During Caesarean Section
NCT01412073
Fluid Absorption in Patients Undergoing Operative Hysteroscopy; Results From a Prospective Controlled Study
NCT04328870
Determination of Blood Loss After CS
NCT04549012
Comparison Study of Oxytocin Versus Tranexamic Acid and Etamsylaye Versus Placebo(Saline)
NCT05273632
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group (A)
Patients will be given uterotonics
oxytocin
Uterotonics will be given in the form of an IV bolus of 10 units of oxytocin immediately with the uterine incision
Group (B)
Patients will not be given uterotonics
placebo
IV bolus of normal saline immediately with the uterine incision
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
oxytocin
Uterotonics will be given in the form of an IV bolus of 10 units of oxytocin immediately with the uterine incision
placebo
IV bolus of normal saline immediately with the uterine incision
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Previous one or more cesarean sections
* Gestational age: \> 32 weeks
* The following ultrasound markers such as "loss of clear retroplacental translucency", "myometrial thinning", "abnormal lacunae", "irregular bladder wall", "utero-vesicalhypervascularity".
* Preoperative hemoglobin more than 10 gm/dl
* Cases with PAS that will undergoing CS Hysterectomy
Exclusion Criteria
* Any known or reported hypersensitivity to the used medication.
* All cases with spontaneous placental separation at laparotomy.
* All patients undergoing conservative management of PAS.
* All cases which necessitate emergency termination.
20 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abdalla Mousa
Lecturer of obgyn Cairo university
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Uterotonics in PASD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.